Loading…
Login
Scholar Register
Business Register
Subscribe
Loading…
Article Title
Abstract
Keyword
Category
MESH Heading
Grant Agency
RCAID
DOI
PMID
PMCID
Author
Affiliation
Email
Journal Title
ISSN
Publisher
Loading…
Contains
Equals
Find an Article
Find an Article (55476309)
Find a Category (124)
Find a Journal (6161)
Find a Scholar (4014)
Find an Academic Assistant (18)
Find an Article PDF (4623024)
Today's Articles (5252)
Subscriber (49407)
Citation(s) in
RCA
4
(from Reference Citation Analysis)
Indexed Articles
Today (0)
Yesterday (0)
This Week (0)
Last Week (0)
Current Month (0)
Last Month (0)
Ranked By
Impact Index Per Article
Citation(s) in
RCA
Results Analysis
Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis
Results Analysis
Year Published
2024 (3)
2023 (1)
Show more
Refine
Article Statistics
PubMed (3)
RCA (3)
SCIE (3)
Open (2)
Refine
Publication Titles
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION (1)
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (1)
CLINICAL AND TRANSLATIONAL ALLERGY (1)
DERMATOLOGY AND THERAPY (1)
Show more
Refine
Category
Allergy (1)
Dermatology (1)
Pharmacology & Pharmacy (1)
Toxicology (1)
Show more
Refine
For:
Zuberbier T
, Beck LA, Bedbrook A, de Bruin-Weller M, Bousquet J, Cork M, Douladiris N, Katoh N, Mortz CG, Werfel T, Wojciech F, Wollenberg A, Siemens K, Stevanovic K, Worm M.
Developing integrated care pathways for atopic dermatitis-Challenges and unmet needs.
Clin Transl Allergy
2023;
13
:e12236. [PMID:
36973955
PMCID:
PMC10040953
DOI:
10.1002/clt2.12236
]
[
Citation(s) in
RCA
: 3
]
[
Impact Index Per Article: 3.0
]
[
Reference Citation Analysis
]
[
What about the content of this article? (
0
)
]
[
Track Full Text
]
[
Journal Information
]
[
Subscribe
]
[
Scholar Register
]
[Received: 01/02/2023]
[Revised: 02/27/2023]
[Accepted: 03/01/2023]
[Indexed: 03/29/2023]
Open
Number
Cited by Other Article(s)
1
Amerio P
, Ferrucci SM, Galluzzo M, Napolitano M, Narcisi A, Levi A, Di Fino S, Palladino C, Patruno C, Rossi M. A Multidisciplinary Approach Is Beneficial in Atopic Dermatitis.
Dermatol Ther (Heidelb)
2024;
14
:1443-1455. [PMID:
38811470
PMCID:
PMC11169114
DOI:
10.1007/s13555-024-01185-1
]
[
Citation(s) in
RCA
: 0
]
[
Impact Index Per Article: 0
]
[
Reference Citation Analysis
]
[
Abstract
]
[
Key Words
]
[
Grants
]
[
Track Full Text
]
[
Journal Information
]
[
Subscribe
]
[
Scholar Register
]
[Received: 04/18/2024]
[Accepted: 05/10/2024]
[Indexed: 05/31/2024]
Open
Abstract
Atopic dermatitis (AD) is a highly heterogeneous chronic inflammatory skin disorder that is frequently associated with a plethora of comorbidities. AD is, therefore, considered a systemic disease impacted by a considerable burden and leading to poor quality of life, especially in patients with moderate-to-severe disease. Since atopic and non-atopic comorbidities can further worsen the disease course, accurate establishment of the patient's individual intrinsic risk profile and needs is crucial and may help in guiding the selection of the best treatment option. Better quality of care for patients with AD can be delivered through a multidisciplinary team led by a dermatologist, for comprehensive patient management. The implementation of a multidisciplinary approach for AD could enhance the delivery of optimised and safe treatments, improve the standard of care and patient outcomes in the short and long term, and prevent or delay the lifelong impact of uncontrolled AD. Understanding the unmet needs, assessing correctly the patient risk profile and enhancing the shared patient-physician decision-making process can lead to disease control and quality-of-life improvement, especially in the context of the introduction of newer treatment for AD. This narrative review is a call for more data to establish standardised patient profiles and multidisciplinary strategies in AD management. In view on the fast-evolving treatments for AD, this review aims at highlighting the importance of a multidisciplinary approach to a comprehensive assessment and holistic care in patients with moderate-to-severe AD.
Collapse
Key Words
Holistic care
Moderate-to-severe atopic dermatitis
Multidisciplinary approach
Collapse
MESH Headings
Collapse
Grants
AbbVie (Italy)
Collapse
Affiliation(s)
Paolo Amerio
Dermatology Unit, Department of Medicine and Aging Science, University of Chieti Pescara, 66100, Chieti, Italy
Silvia Mariel Ferrucci
Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
Marco Galluzzo
Dermatology Unit, Fondazione Policlinico "Tor Vergata", Rome, Italy
Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy
Maddalena Napolitano
Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy.
Alessandra Narcisi
Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy
Anna Levi
AbbVie SrL, Rome, Italy
Sara Di Fino
AbbVie SrL, Rome, Italy
Chiara Palladino
AbbVie SrL, Rome, Italy
Cataldo Patruno
Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy
Mariateresa Rossi
Department of Clinical and Experimental Sciences, Dermatology Unit, University of Brescia, Brescia, Italy
Collapse
2
Cayci AB
, Rathbone AP, Lindsey L, Richardson C. Pharmacy Students' Lived Experiences With Atopic Dermatitis Inform Perceptions of Learning in the Curriculum.
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION
2024;
88
:100651. [PMID:
38218340
DOI:
10.1016/j.ajpe.2024.100651
]
[
Citation(s) in
RCA
: 0
]
[
Impact Index Per Article: 0
]
[
Reference Citation Analysis
]
[
Abstract
]
[
Key Words
]
[
MESH Headings
]
[
Track Full Text
]
[
Subscribe
]
[
Scholar Register
]
[Received: 10/05/2023]
[Revised: 12/25/2023]
[Accepted: 01/07/2024]
[Indexed: 01/15/2024]
Abstract
OBJECTIVE
To explore the impact of lived experiences of pharmacy students with atopic dermatitis (AD) on perceptions of learning in pharmacy curriculum.
METHODS
An exploratory qualitative study was conducted with pharmacy students in the United Kingdom to understand how their lived experiences affect their perception of AD in pharmacy curriculum. Semistructured interviews were conducted, and a thematic analysis method was followed. Firstly, codes were created, and then relevant codes were combined to identify themes.
RESULTS
Thirteen pharmacy students were interviewed. Study findings showed pharmacy students support teaching with a holistic approach to management and patient-centered care in AD in pharmacy curriculum. Although students had empathy and moral support for patients, they also described a need for teaching on the mental health effects of AD in pharmacy education.
CONCLUSION
This brief report explores the role of lived experience of pharmacy students in considering the provision of holistic, patient-centered care in AD teaching in pharmacy education. Participants also suggest the need within the pharmacy curriculum for training to provide mental health advice to patients with AD.
Collapse
Key Words
Atopic dermatitis
Lived experience
Pharmacy education
Pharmacy student
Collapse
MESH Headings
Humans
Students, Pharmacy/psychology
Dermatitis, Atopic/therapy
Education, Pharmacy/methods
Curriculum
Learning
Collapse
Grants
Collapse
Affiliation(s)
Abdi Berk Cayci
School of Pharmacy, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom; Faculty of Pharmacy, Hacettepe University, Ankara, Türkiye.
Adam Pattison Rathbone
School of Pharmacy, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom
Laura Lindsey
School of Pharmacy, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom
Charlotte Richardson
School of Pharmacy, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom
Collapse
3
Tiligada E
, Gafarov D, Zaimi M, Vitte J, Levi-Schaffer F. Novel Immunopharmacological Drugs for the Treatment of Allergic Diseases.
Annu Rev Pharmacol Toxicol
2024;
64
:481-506. [PMID:
37722722
DOI:
10.1146/annurev-pharmtox-051623-091038
]
[
Citation(s) in
RCA
: 0
]
[
Impact Index Per Article: 0
]
[
Reference Citation Analysis
]
[
Abstract
]
[
Key Words
]
[
MESH Headings
]
[
Track Full Text
]
[
Journal Information
]
[
Subscribe
]
[
Scholar Register
]
[Indexed: 09/20/2023]
Abstract
The exponential rise in the prevalence of allergic diseases since the mid-twentieth century has led to a genuine public health emergency and has also fostered major progress in research on the underlying mechanisms and potential treatments. The management of allergic diseases benefits from the biological revolution, with an array of novel immunomodulatory therapeutic and investigational tools targeting players of allergic inflammation at distinct pathophysiological steps. Prominent examples include therapeutic monoclonal antibodies against cytokines, alarmins, and their receptors, as well as small-molecule modifiers of signal transduction mainly mediated by Janus kinases and Bruton's tyrosine kinases. However, the first-line therapeutic options have yet to switch from symptomatic to disease-modifying interventions. Here we present an overview of available drugs in the context of our current understanding of allergy pathophysiology, identify potential therapeutic targets, and conclude by providing a selection of candidate immunopharmacological molecules under investigation for potential future use in allergic diseases.
Collapse
Key Words
allergy
biologics
eosinophils
immunopharmacology
mast cells
small-molecule drugs
Collapse
MESH Headings
Humans
Hypersensitivity/drug therapy
Antibodies, Monoclonal
Cytokines
Inflammation
Signal Transduction
Collapse
Grants
Collapse
Affiliation(s)
Ekaterini Tiligada
Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel;
Daria Gafarov
Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel;
Maria Zaimi
Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Joana Vitte
Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel;
Desbrest Institute of Epidemiology and Public Health, University of Montpellier, INSERM
Montpellier, France
Francesca Levi-Schaffer
Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel;
Collapse
4
Zuberbier T
, Abdul Latiff A, Aggelidis X, Augustin M, Balan R, Bangert C, Beck L, Bieber T, Bernstein JA, Bertolin Colilla M, Berardi A, Bedbrook A, Bindslev‐Jensen C, Bousquet J, de Bruin‐Weller M, Bruscky D, Buyuktiryaki B, Canonica GW, Castro C, Chanturidze N, Chong‐Neto HJ, Chu C, Chularojanamontri L, Cork M, Criado RFJ, Barredo LC, Custovic A, Darsow U, Emurlai A, de Pablo A, Del Giacco S, Girolomoni G, Deleva Jovanova T, Deleuran M, Douladiris N, Duarte B, Dubakiene R, Eller E, Engel‐Yeger B, Ensina LF, Filho NR, Flohr C, Fomina D, Francuzik W, Galimberti ML, Giménez‐Arnau AM, Godse K, Mortz CG, Gotua M, Hide M, Hoetzenecker W, Hunzelmann N, Irvine A, Jack C, Kanavarou I, Katoh N, Kinaciyan T, Kocatürk E, Kulthanan K, Lapeere H, Lau S, Machado Forti Nastri M, Makris M, Mansour E, Marsland A, Morelo Rocha Felix M, Moschione Castro AP, Nettis E, Nicolas JF, Nosbaum A, Odemyr M, Papapostolou N, Parisi CAS, Paudel S, Peter J, Pokharel P, Puig L, Quint T, Ramon GD, Regateiro F, Ricci G, Rosario C, Sackesen C, Schmid‐Grendelmeier P, Serra‐Baldrich E, Siemens K, Smith C, Staubach P, Stevanovic K, Su‐Kücük Ö, Sussman G, Tavecchio S, Teovska Mitrevska N, Thaci D, Toubi E, Traidl‐Hoffmann C, Treudler R, Vadasz Z, van Hofman I, Ventura MT, Wang Z, Werfel T, Wollenberg A, Yang A, Weng Yew Y, Zhao Z, Zwiener R, Worm M. A concept for integrated care pathways for atopic dermatitis-A GA
2
LEN ADCARE initiative.
Clin Transl Allergy
2023;
13
:e12299. [PMID:
37746794
PMCID:
PMC10500634
DOI:
10.1002/clt2.12299
]
[
Citation(s) in
RCA
: 0
]
[
Impact Index Per Article: 0
]
[
Reference Citation Analysis
]
[
Abstract
]
[
Key Words
]
[
Grants
]
[
Track Full Text
]
[
Journal Information
]
[
Subscribe
]
[
Scholar Register
]
[Received: 07/25/2023]
[Accepted: 08/23/2023]
[Indexed: 09/26/2023]
Open
Abstract
INTRODUCTION
The integrated care pathways for atopic dermatitis (AD-ICPs) aim to bridge the gap between existing AD treatment evidence-based guidelines and expert opinion based on daily practice by offering a structured multidisciplinary plan for patient management of AD. ICPs have the potential to enhance guideline recommendations by combining interventions and aspects from different guidelines, integrating quality assurance, and describing co-ordination of care. Most importantly, patients can enter the ICPs at any level depending on AD severity, resources available in their country, and economic factors such as differences in insurance reimbursement systems.
METHODS
The GA2 LEN ADCARE network and partners as well as all stakeholders, abbreviated as the AD-ICPs working group, were involved in the discussion and preparation of the AD ICPs during a series of subgroup workshops and meetings in years 2020 and 2021, after which the document was circulated within all GAL2 EN ADCARE centres.
RESULTS
The AD-ICPs outline the diagnostic procedures, possible co-morbidities, different available treatment options including differential approaches for the pediatric population, and the role of the pharmacists and other stakeholders, as well as remaining unmet needs in the management of AD.
CONCLUSION
The AD-ICPs provide a multidisciplinary plan for improved diagnosis, treatment, and patient feedback in AD management, as well as addressing critical unmet needs, including improved access to care, training specialists, implementation of educational programs, assessment on the impact of climate change, and fostering a personalised treatment approach. By focusing on these key areas, the initiative aims to pave the way for a brighter future in the management of AD.
Collapse
Key Words
ICP
atopic dermatitis
eczema
guidance
integrated care pathways
multidisciplinary
prevention
treatment
Collapse
MESH Headings
Collapse
Grants
MR/K002449/1 Medical Research Council
MR/S002359/1 Medical Research Council
MR/T031565/1 Medical Research Council
MR/K002449/2 Medical Research Council
MR/S025340/1 Medical Research Council
MR/W028352/1 Medical Research Council
Collapse
Affiliation(s)
Torsten Zuberbier
Institute of Allergology
Charité ‐ Universitätsmedizin Berlin
Berlin
Germany
Allergology and Immunology
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
Berlin
Germany
Amir Abdul Latiff
Pantai Hospital Kuala Lumpur
Kuala Lumpur
Malaysia
Xenofon Aggelidis
Allergy Unit
2nd Department of Dermatology and Venereology
National and Kapodistrian University of Athens
University General Hospital "Attikon"
Athens
Greece
Matthias Augustin
University Medical Center Hamburg‐Eppendorf
Hamburg
Germany
Institute for Health Services Research in Dermatology and Nursing
Hamburg
Germany
Radu‐Gheorghe Balan
Institutul Regional de Gastroenterologie si Hepatologie
Cluj‐Napoca
Romania
Christine Bangert
Department of Dermatology
Medical University of Vienna
Vienna
Austria
Lisa Beck
University of Rochester Medical Center
Rochester
New York
USA
Thomas Bieber
University Hospital of Bonn
Bonn
Germany
Christine Kühne‐Center of Allergy Research and Education
Davos
Switzerland
Jonathan A. Bernstein
University of Cincinnati College of Medicine
Cincinnati
Ohio
USA
Marta Bertolin Colilla
Hospital del Mar
Barcelona
Spain
Alejandro Berardi
Instituto de Asma
Alergia y Enfermedades Respiratorias
Corrientes
Argentina
Anna Bedbrook
MACVIA‐France
Fondation Partenariale FMC VIA‐LR
Montpellier
France
Carsten Bindslev‐Jensen
Department of Dermatology and Allergy Centre
Odense Research Centre for Anaphylaxis (ORCA)
Odense University Hospital
University of Southern Denmark
Odense C
Denmark
Jean Bousquet
Division of Allergy and Immunology
Complexo Hospital de Clinicas Federal University of Paraná
Curitiba
Brazil
Marjolein de Bruin‐Weller
Department of Dermatology/Allergology
National Expertise Center for Atopic Dermatitis
University Medical Center Utrecht
Utrecht
The Netherlands
Dayanne Bruscky
Federal University of Pernambuco
Recife
Brazil
Betul Buyuktiryaki
Division of Pediatric Allergy
Koc University Hospital
Istanbul
Turkey
Giorgio Walter Canonica
Personalized Medicine, Asthma and Allergy
IRCCS Humanitas Research Hospital
Rozzano, Milan
Italy
Carla Castro
Department of Dermatology
Hospital Universitario Austral
Universidad Austral
Buenos Aires
Argentina
Natia Chanturidze
Center of Allergy and Immunology
Tbilisi
Georgia
Herberto Jose Chong‐Neto
Division of Allergy and Immunology
Complexo Hospital de Clinicas Federal University of Paraná
Curitiba
Brazil
Chia‐Yu Chu
Department of Dermatology
National Taiwan University Hospital
Taipei
Taiwan
Leena Chularojanamontri
Department of Dermatology
Faculty of Medicine Siriraj Hospital
Mahidol University
Bangkok
Thailand
Michael Cork
Sheffield Dermatology Research
IICD
University of Sheffield
Sheffield
UK
Roberta F. J. Criado
Alergoskin Alergia e Dermatologia
Santo Andre
Brazil
Department of Dermatology
Centro Universitario FMABC
Santo Andre
Brazil
Laia Curto Barredo
Hospital del Mar
Parc de Salut Mar
Barcelona
Spain
Adnan Custovic
National Heart and Lung Institute
Imperial College
London
UK
Ulf Darsow
Department of Dermatology and Allergy Biederstein
Technische Universität München
Munich
Germany
Arben Emurlai
Clinical Hospital Tetovo
Tetovo
North Macedonia
Ana de Pablo
Hospital Universitario Austral
Pilar
Argentina
Stefano Del Giacco
Allergy and Clinical Immunology
University of Cagliari
Sardinia
Italy
Giampiero Girolomoni
Section of Dermatology
Department of Medicine
University of Verona
Verona
Italy
Tanja Deleva Jovanova
Health Center Skoplje
Skoplje
North Macedonia
Mette Deleuran
Department of Dermatology
Aarhus University Hospital
Aarhus
Denmark
Nikolaos Douladiris
Allergy Unit
2nd Department of Dermatology and Venereology
National and Kapodistrian University of Athens
University General Hospital "Attikon"
Athens
Greece
Bruno Duarte
Hospital Santo Antonio dos Capuchos
Centro Universitário de Lisboa Central
Lisbon
Portugal
Ruta Dubakiene
Department of Immunology and Allergology
Medical Faculty
Clinics of Chest Diseases
Vilnius University
Vilnius
Lithuania
Esben Eller
Department of Dermatology and Allergy Centre
Odense Research Centre for Anaphylaxis (ORCA)
Odense University Hospital
University of Southern Denmark
Odense C
Denmark
Batya Engel‐Yeger
Occupational Therapy Department
Faculty of Social Welfare and Health Sciences
University of Haifa
Haifa
Israel
Luis Felipe Ensina
CPAlpha Clinical Research Center
Barueri – São Paulo
Brazil
Nelson Rosario Filho
Division of Allergy and Immunology
Complexo Hospital de Clinicas Federal University of Paraná
Curitiba
Brazil
Carsten Flohr
St John's Institute of Dermatology
St Thomas' Hospital
London
UK
Daria Fomina
Center of Allergy and Immunology
Clinical State Hospital 52
Moscow Ministry of Healthcare
Moscow
Russian Federation
Wojciech Francuzik
Division of Allergy and Immunology
Department of Dermatology, Venereology and Allergology
Charité – Universitätsmedizin Berlin
corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin
Berlin
Germany
Maria Laura Galimberti
Hospital Italiano de Buenos Aires
Buenos Aires
Argentina
Ana M. Giménez‐Arnau
Dermatology Department
Hospital del Mar
IMIM
Universitat Autonoma y Universitat Pompeu Fabra
Barcelona
Spain
Kiran Godse
D.Y. Patil University
Navi Mumbai
Maharashtra
India
Charlotte Gotthard Mortz
Department of Dermatology and Allergy Centre
Odense Research Centre for Anaphylaxis (ORCA)
Odense University Hospital
University of Southern Denmark
Odense C
Denmark
Maia Gotua
Center of Allergy and Immunology
Tbilisi
Georgia
Michihiro Hide
Department of Dermatology
Hiroshima University Hospital
Hiroshima
Japan
Wolfram Hoetzenecker
Department of Dermatology
Kepler University Hospital
Linz
Austria
Nicolas Hunzelmann
Department of Dermatology
University of Cologne
Cologne
Germany
Alan Irvine
Clinical Medicine
Trinity College Dublin
Dublin
Ireland
Carolyn Jack
Research Institute of the McGill University Health Centre
Montreal
Quebec
Canada
Ioanna Kanavarou
Allergy Unit
2nd Department of Dermatology and Venereology
National and Kapodistrian University of Athens
University General Hospital "Attikon"
Athens
Greece
Norito Katoh
Department of Dermatology
Kyoto Prefectural University of Medicine
Kyoto
Japan
Tamar Kinaciyan
Department of Dermatology
Medical University of Vienna
Vienna
Austria
Emek Kocatürk
Division of Pediatric Allergy
Koc University Hospital
Istanbul
Turkey
Kanokvalai Kulthanan
Department of Dermatology
Faculty of Medicine Siriraj Hospital
Mahidol University
Bangkok
Thailand
Hilde Lapeere
Ghent University Hospital
Ghent
Belgium
Susanne Lau
Charité‐Universitätsmedizin Berlin
Berlin
Germany
Mariana Machado Forti Nastri
Faculdade de Medicina
Hospital das Clínicas
Instituto da Criança e do Adolescente
Universidade de São Paulo
São Paulo
Brazil
Michael Makris
Allergy Unit
2nd Department of Dermatology and Venereology
National and Kapodistrian University of Athens
University General Hospital "Attikon"
Athens
Greece
Eli Mansour
Division of Allergy and Immunology
Department of Clinical Medicine
University of Campinas
Campinas
Brazil
Alexander Marsland
Salford Royal Foundation Trust ‐ University of Manchester and Spire Manchester Hospital
Manchester
UK
Mara Morelo Rocha Felix
AlergoLife Clinici
Rio de Janeiro
Brazil
Ana Paula Moschione Castro
Instituto da Criança
Rio de Janeiro
Brazil
Eustachio Nettis
Department of Emergency and Organ Transplantation
School and Chair of Allergology and Clinical Immunology
University of Bari ‐ Aldo Moro
Bari
Italy
J. F. Nicolas
Department of Clinical Immunology and Allergy
Lyon‐Sud University Hospital
CIRI/INSERM U1111
Lyon
France
Audrey Nosbaum
Service d'Allergologie et Immunologie Clinique
Centre Hospitalier Lyon Sud
Hospices Civils de Lyon
Pierre‐Bénite
France
Centre International de Recherche en Infectiologie
INSERM U1111
CNRS UMR 5308
UCBL1
ENS de Lyon
Lyon
France
Mikaela Odemyr
EFA European Federation of Allergy and Airways Diseases Patients' Associations
Brussels
Belgium
President of the Swedish Asthma and Allergy Association
Stockholm
Sweden
Niki Papapostolou
Allergy Unit
2nd Department of Dermatology and Venereology
National and Kapodistrian University of Athens
University General Hospital "Attikon"
Athens
Greece
Claudio A. S. Parisi
Dermatology Department
Hospital del Mar
IMIM
Universitat Autonoma y Universitat Pompeu Fabra
Barcelona
Spain
Sushil Paudel
Center Civil Service Hospital
Kathmandu
Nepal
Jonny Peter
Division of Allergy and Clinical Immunology
Department of Medicine
University of Cape Town
Cape Town
South Africa
Allergy and Immunology Unit
University of Cape Town Lung Institute
Cape Town
South Africa
Prakash Pokharel
Instituto de Alergia e Inmunologia del Sur
Bahia Blanca
Buenos Aires
Argentina
Allergia e Inmunologia Section
Hospital Italiano Regional del Sur
Bahia Blanca
Buenos Aires
Argentina
Luis Puig
Department of Dermatology
Hospital de la Santa Creu i Sant Pau
Barcelona
Spain
Tamara Quint
Department of Dermatology
Medical University of Vienna
Vienna
Austria
German Dario Ramon
Instituto de Alergia e Inmunologia del Sur
Bahia Blanca
Buenos Aires
Argentina
Allergia e Inmunologia Section
Hospital Italiano Regional del Sur
Bahia Blanca
Buenos Aires
Argentina
Frederico Regateiro
Centro Hospitalar Universitário de Coimbra
Coimbra
Portugal
Giampaolo Ricci
Department of Medical and Surgical Sciences DIMEC
University of Bologna
Bologna
Italy
Cristine Rosario
Federal University of Parana
Curitiba
Brazil
Cansin Sackesen
Division of Pediatric Allergy
Koc University Hospital
Istanbul
Turkey
Peter Schmid‐Grendelmeier
Department of Dermatology Allergy Unit
University Hospital of Zürich
Zürich
Switzerland
Chrstine Kèhne Center for Allergy Research and Education CK_CARE
Davos
Switzerland
Esther Serra‐Baldrich
Centre International de Recherche en Infectiologie
INSERM U1111
CNRS UMR 5308
UCBL1
ENS de Lyon
Lyon
France
Kristina Siemens
King's College London
London
UK
Cathrine Smith
St John's Institute of Dermatology
Guys and St Thomas' NHS Trust
London
UK
Petra Staubach
Department of Dermatology and Allergy
Hautklinik und Poliklinik der Universitätsmedizin
University Medical Center
Mainz
Germany
Katarina Stevanovic
Institute of Allergology
Charité ‐ Universitätsmedizin Berlin
Berlin
Germany
Allergology and Immunology
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
Berlin
Germany
Özlem Su‐Kücük
Department of Dermatology
Faculty of Medicine
Bezmialem Vakif University
Istanbul
Turkey
Gordon Sussman
Faculty of Medicine
University of Toronto
Toronto
Ontario
Canada
Simona Tavecchio
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan
Italy
Natasa Teovska Mitrevska
ReMedika General Hospital
Skopje
North Macedonia
Diamant Thaci
Center for Comprehensive Inflammation Medicine
University of Lübeck
Lübeck
Germany
Elias Toubi
Allergy and Clinical Immunology
Holy Family Hospital
Nazareth
Israel
Claudia Traidl‐Hoffmann
Environmental Medicine
Faculty of Medicine
University of Augsburg
Augsburg
Germany
Regina Treudler
Universtiy Leipzig Medical Faculty
Leipziger Interdisziplinäres Centrum für Allergologie
Leipzig
Germany
Zahava Vadasz
Bnai‐Zion Medical Center
Haifa
Israel
Ingrid van Hofman
GALEN Network
Berlin
Germany
Maria Teresa Ventura
University of Bari Aldo Moro
Bari
Italy
Zhao Wang
Department of Dermatology
Second Affiliated Hospital
Northwest Hospital
Xi'an Jiaotong University
Xi'an
Shaanxi
China
Thomas Werfel
Department of Dermatology and Allergy
Hannover Medical School
Hannover
Germany
Andreas Wollenberg
Department of Dermatology and Allergy
Ludwig‐Maximilian‐University
Munich
Germany
Department of Dermatology
Free University Brussels
University Hospital Brussels
Brussels
Belgium
Ariana Yang
Division of Allergy and Clinical Immunology of University of Sao Paulo
São Paulo
Brazil
Faculty of Medical Sciences of UNICAMP
São Paulo
Brazil
Yik Weng Yew
National Skin Centre
Singapore
Singapore
Zuotao Zhao
Department of Dermatology
First Hospital Peking University
Beijing
China
Ricardo Zwiener
Medicina Interna y Alergología e Inmunología Clínica
Hospital Universitario Austral
Pilar
Argentina
Margitta Worm
University Medical Center Hamburg‐Eppendorf
Hamburg
Germany
Institute for Health Services Research in Dermatology and Nursing
Hamburg
Germany
Collapse
Page 1 of 1
1
Loading…
Loading…
Export Articles to File
Export Citation Analysis
Export Citation Analysis
Article Number From
to
A maximum of 600 records can be exported at a time.
Format:
*
Excel
Plain Text
PDF
WORD
Invalid value
Loading…
Click to Download the Exported File
Loading…
Loading…
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Select the Category
Loading…
Loading…
Impact Index Per Article
Calculation for Impact Index Per Article
Times Cited ÷ Number of Years = Impact Index Per Article
TM
Loading…